NCT04235322 - Study of 2LHERP® in Genital Herpes Infections | Biotech Hunter

Enrollment

6

Participants

Timeline

Start Date

January 25, 2021

Primary Completion Date

April 18, 2023

Study Completion Date

April 18, 2023

Conditions

Herpes Simplex, Genital

Interventions

DRUG

2LHERP®

The treatment schema consists in taking the content of one capsule a day, 15-30 minutes before breakfast, on an empty stomach, sequentially, according to capsules' numerical order: 1 through 10. When capsule number 10 is taken, capsule 1 of the next blister should be taken on the next day to continue the treatment. The duration of treatment will be 6 months of continuous intake of the content of 1 capsule/day.

DRUG

Placebo

The treatment schema consists in taking the content of one capsule a day, 15-30 minutes before breakfast, on an empty stomach, sequentially, according to capsules' numerical order: 1 through 10. When capsule number 10 is taken, capsule 1 of the next blister should be taken on the next day to continue the treatment. The duration of treatment will be 6 months of continuous intake of the content of 1 capsule/day.

Trial Locations (13)

1000

Dr MANOUACH Fatiha, Brussels

1050

Dr VERHEVEN Cécile, Brussels

1180

Private Practice, Brussels

1400

Dr PETTEAU Myriam, Nivelles

1480

Private Practice, Oisquercq

4500

Centre Hospitalier Regional de Huy, Huy

5300

Polyclinique D'Andenne, Andenne

6042

Private practice, Lodelinsart

CHU Charleroi - Hopital Marie Curie, Charleroi

6534

Cabinet privé, Gozée

6800

Private Practice, Libramont

Vivalia - Centre Hospitalier de L'Ardenne - Libramont Chevigny, Libramont

6831

Dr ROULEFF Denis, Noirefontaine